Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Anavex Life Sciences Corp AVXL

Healthcare Biotechnology
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system (CNS) diseases with unmet need. The Company analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of... see more

Recent & Breaking News (NDAQ:AVXL)

Anavex Reports Fiscal First Quarter 2016 Financial Results

GlobeNewswire February 8, 2016

IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces Ongoing Investigation of Anavex Life Sciences Corp. and Urges Investors with Losses in Excess of $250,000 to Contact the Firm

Business Wire February 5, 2016

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Anavex Life Sciences Corp. To Contact The Firm Before Upcoming Lead Plaintiff Deadline

PR Newswire February 5, 2016

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces a Securities Fraud Class Action Lawsuit Has Been Filed Against Anavex Life Sciences Corp. -- AVXL

GlobeNewswire February 5, 2016

INVESTOR ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Involving Anavex Life Sciences Corp. and a Lead Plaintiff Deadline of February 29, 2016

Business Wire February 5, 2016

Cohen Milstein Sellers & Toll PLLC Announces the Investigation of Anavex Life Sciences Corp. -- AVXL

GlobeNewswire February 4, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Anavex Life Sciences Corp. of Class Action Lawsuit and a Lead Plaintiff Deadline of February 29, 2016 - AVXL

Accesswire February 3, 2016

Insider Alert: Here's Why These Small Caps Could Be Ready To Rally

Accesswire February 3, 2016

Anavex to Present at 18th Annual BIO CEO & Investor Conference on February 9th 2016

GlobeNewswire February 2, 2016

SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Anavex Life Sciences Corp. - AVXL

PR Newswire February 1, 2016

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Involving Anavex Life Sciences Corp. and a Lead Plaintiff Deadline of February 29, 2016 - AVXL

PR Newswire February 1, 2016

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Anavex Life Sciences Corp. of Class Action Lawsuit and Upcoming Deadline - AVXL

PR Newswire January 29, 2016

Deadline in Lawsuit for Investors in Anavex Life Sciences Corp. (NASDAQ:AVXL) Shares Announced by Shareholders Foundation

GlobeNewswire January 27, 2016

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Anavex Life Sciences Corp. of Class Action Lawsuit and a Lead Plaintiff Deadline of February 29, 2016

Business Wire January 25, 2016

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Anavex Life Sciences Corp. to Contact the Firm Before Upcoming Lead Plaintiff Deadline

Marketwired January 23, 2016

Hagens Berman Reminds Anavex Life Sciences Corp. (NASDAQCM: AVXL) Investors of February 29, 2016 Lead Plaintiff Deadline in Securities Fraud Class Action Related to Stock Promotion

GlobeNewswire January 22, 2016

INVESTOR ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Involving Anavex Life Sciences Corp. and a Lead Plaintiff Deadline of February 29, 2016 - AVXL

Business Wire January 19, 2016

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses in Excess of $100,000 from Investment in Anavex Life Sciences Corp. to Contact Brower Piven before the Lead Plaintiff Deadline in Class Action Lawsuit

Business Wire January 15, 2016

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Anavex Life Sciences Corp. of Class Action Lawsuit and a Lead Plaintiff Deadline of February 29, 2016 - AVXL

Accesswire January 15, 2016

SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Anavex Life Sciences Corp. of Class Action Lawsuit and Upcoming Deadline - AVXL

GlobeNewswire January 15, 2016